Obesity Clinical Trials

Dr. John Rubino and his staff at Multi-Specialty Research Associates of NC are conducting a clinical research study of an investigational medication for weight loss. Study participants must be between 18 and 65 years old, non-diabetic, and non-smoker for at least a year. Qualified subjects will receive: Study-related physical exams ...

This study will require one visit (approx. one half hour) to Columbia Presbyterian Medical Center in New York, or your private physician or clinic. The visit will cover the following: Discussing and signing an informed consent Family and medical history Measurements: weight and height, blood drawing We offer $25 per ...

Researchers at the University of Kentucky are inviting you to participate in a study to examine the role of inflammation in the progression of pre-diabetes to type 2 diabetes. This study involves one to two visits per year for up to three years. Participants will be compensated for their time ...

Researchers at the University of Kentucky are inviting you to participate in a study to examine the role of inflammation in the progression from overweight and healthy to overweight with diabetes. This study involves one to two visits. Participants will be compensated for their time and participation.

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. ...

A research study is evaluating the effects of an investigational dose of an FDA-approved medication for cardiovascular outcomes in adults who are overweight.  

Emergency data suggest 17OHP-C may be less efficacious in obese women. Since obesity is associated with lower levels of plasma 17OHP-C, the investigator hypothesize that higher doses of 17OHP-C may help to prevent spontaneous PTB among obese women. The study aims to compare the pharmacokinetics of 17 OHP-C in obese ...

The purpose of this study is to determine the effect of sleep duration on blood glucose (sugar) control. Participants will visit the research center a total of 11 times including two 2-night inpatient stays and three 1-night inpatient stays. Outpatient visits will range from less than 1 hour to approximately ...

This study will look mainly at the effect of semaglutide on cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. Approximately 17,500 men and women across the world will take part in this study.  

Are you or your child very overweight? Did the weight gain start at a very early age? It could be due to your genetics. You may be eligible for a genetic testing study to find out if the extra weight is due to your genetics.   If you are interested ...